Note 15 - Subsequent Events	9 Months Ended
Sep. 30, 2025
Notes to Financial Statements
Subsequent Events [Text Block]	15. Subsequent Events The Company evaluates and discloses subsequent events as required by FASB ASC Topic No. 855, Subsequent Events. The Topic establishes general standards of accounting for and disclosure of events that occur after the balance sheet date, but before the financial statements are issued or are available to be issued. On November 5, 2025, the Company announced that it has entered into definitive agreements with respect to two separate offerings; a registered offering with certain institutional and accredited investors, and an unregistered offering with the Company’s chief executive officer. Both offerings have been priced based on the market value of the offered securities as of the time of signing the purchase agreements and the Company will issue approximately 4.0 million shares of Common Stock and an equivalent amount of warrants exercisable for one share of the Company’s Common Stock at an exercise price of $0.6708 per share. The aggregate gross proceeds of the two offerings are expected to be approximately $2.7 million, which includes a committed investment of $1.5 million from the Company’s chief executive officer. The offerings are expected to close on or about November 6, 2025, subject to customary closing conditions.

Note 15 - Subsequent Events

9 Months Ended

Sep. 30, 2025

15. Subsequent Events

The Company evaluates and discloses subsequent events as required by FASB ASC Topic No. 855, Subsequent Events. The Topic establishes general standards of accounting for and disclosure of events that occur after the balance sheet date, but before the financial statements are issued or are available to be issued.

On November 5, 2025, the Company announced that it has entered into definitive agreements with respect to two separate offerings; a registered offering with certain institutional and accredited investors, and an unregistered offering with the Company’s chief executive officer. Both offerings have been priced based on the market value of the offered securities as of the time of signing the purchase agreements and the Company will issue approximately 4.0 million shares of Common Stock and an equivalent amount of warrants exercisable for one share of the Company’s Common Stock at an exercise price of $0.6708 per share. The aggregate gross proceeds of the two offerings are expected to be approximately $2.7 million, which includes a committed investment of $1.5 million from the Company’s chief executive officer. The offerings are expected to close on or about November 6, 2025, subject to customary closing conditions.